Psyence Biomedical Ltd. (Nasdaq: PBM) (“Psyence BioMed” or the “Company”), a clinical-stage biopharmaceutical company developing nature-derived psychedelic therapeutics, today announced that the ...

The ground-plus-one Art Deco structure, spread over a 1,355 sq metre plot with a built-up area of around 8,480.68 sq ft, is ...

Emyria unveils Empax global partnership platform to link international sponsors with its clinical delivery network; Psyence ...

Greenwich LifeSciences, Inc. (Nasdaq: GLSI) (the 'Company'), a clinical-stage biopharmaceutical company focused on its Phase III clinical trial, FLAMINGO-01, which is evaluating Fast Track designated ...

The ground-plus-one bungalow sits on a 1,355 sq metre plot with a built-up area of approximately 8,480.68 sq ft, and also ...

The frequency of DTH reactions increased by approximately 4x (290%) in the total open-label non-HLA-A*02 population, increasing from 5.2% of the patients experiencing a DTH reaction at baseline, prior ...

Emyria says clinical delivery capacity, not drug development, is becoming a key operational consideration in next-generation ...

Enrollment underway at Mackay Base Hospital in Queensland, Australia; additional sites in final activation stages ...

The Hollystown site was acquired by Dublin GAA from Glenveigh Homes in November 2020 ...